Patients With Diabetes Mellitus on Drug Treatment on the List or Already Undergoing Orthotopic Liver Transplantation

Recruiting

• Conditions: Liver Transplant; Diabetes Mellitus Type 2

• Registration Number: NCT06816303
• Lead Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Brief Summary

observational study through which we aim to collect information on metabolic compensation, the degree of satisfaction with hypoglycemic therapy, the onset of complications of diabetes or liver disease, evaluation of survival, in patients on the list for at least three months or already undergoing liver transplantation for at least three months

Detailed Description

Not available

Study Timeline

• Study Start: 2021-11-19
• Status Verified: 2024-10
• Study First Submitted: 2024-11-28
• Study First Submitted QC: 2025-02-06
• Last Update Submitted: 2025-02-06
• Study First Posted: 2025-02-10
• Last Update Posted: 2025-02-10
• Primary Completion: 2025-06-30
• Study Completion: 2025-06-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• type 2 diabetes mellitus
• presence on the list for OLT for at least 3 months or have already been submitted to OLT for at least 3 months
• age ≥ 18 years
• signature of written informed consent to participate in the observational study, either by the participant or legal guardian

Exclusion Criteria

• Pregnancy or breastfeeding

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
glycosilated hemoglobin (%)	through study completion, an average of 5 years	glycometabolic control in relation to therapy

Secondary Outcome Measures

Name	Time	Method
degree of satisfaction with therapy	through study completion, an average of 5 years	degree of satisfaction with therapy through the administration of Diabetes Treatment Satisfaction Questionnaire (DTSQ)

Trial Locations

Locations (1)

Lucia Brodosi; 🇮🇹 Bologna, BO, Italy